2Bonadonna G, Valagussa P, Molitemi A, et al. Adjuvant cyclophosphamide, metho-trexate, and fluorouracil in node-positive breast cancer[J]. N Engl J Med, 1995,332(14) : 901-906.
3Fisher B, Brown AM, Dimitrov NV, et al. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, metho-trexate, and fluorouracil in positive-node breast cancer patients with tamoxifen nonresponsive tumors : results from the National Surgical Adjuvant Breast and.Bowel Project B-15[J].J Clin Oncol,1990,8(9):1483-1496.
4Bull JM, Tormey DC, Li SH, et al. A randomized conrparative trial of adriamycin versus metho-trexate in combination drug therapy[ J]. Cancer, 1978,41 : 1649-1657.
1Gianni L,Munzone E,Capri G,et al.Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study[].Journal of Clinical Oncology.1995
2Sledge GW,Neuberg D,Bernardo P,et al.Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193)[].Journal of Clinical Oncology.2003
3Smith IC,Heys SD,Hutcheon AW,et al.Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel[].Journal of Clinical Oncology.2002
